Ingestible optoelectronic capsules enable bidirectional communication with engineered microbes for controllable therapeutic interventions
Top Cited Papers
- 28 July 2025
- journal article
- research article
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (8) , 1841-1853
Abstract
Engineered microbes can be used for biomolecular sensing and therapeutic interventions. However, they cannot be monitored and controlled while in vivo. Here we combine optogenetically engineered Escherichia coli Nissle 1917, an ingestible optoelectronic capsule and a wireless smartphone to establish a bidirectional biological–optical–electronic signal processing chain for diagnostic or therapeutic capabilities under user control. As a proof of concept, we engineered E. coli Nissle 1917 to detect inflammation-associated nitric oxide in the pig gut and generate a bioluminescent signal for diagnosis of colitis. This signal is transduced by the optoelectronic capsule into a wireless electrical signal and remotely monitored by a smartphone. Smartphone wireless signals activate LED irradiation in the optoelectronic capsule, in turn activating the microbial expression and secretion of an anti-inflammatory nanobody to alleviate colitis in pigs. This approach highlights the potential for integrating synthetic biology and optoelectronics for digital health monitoring and controllable intervention.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- A Miniaturized Escherichia coli Green Light Sensor with High Dynamic RangeChemBioChem, 2018
- Engineering bacteria for diagnostic and therapeutic applicationsNature Reviews Microbiology, 2018
- Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal modelsNature Communications, 2017
- Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammationMolecular Systems Biology, 2017
- Type I Protein Secretion—Deceptively Simple yet with a Wide Range of Mechanistic Variability across the FamilyEcoSal Plus, 2016
- Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2016
- Toehold gene switches make big footprintsNature, 2014
- Capsule endoscopy and deep enteroscopyEndoscopy, 2014
- Engineered E. coli That Detect and Respond to Gut Inflammation through Nitric Oxide SensingACS Synthetic Biology, 2012
- Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexesJournal of Molecular Biology, 1992